Clinical trial
Irinotecan in Treating Patients With Refractory Solid Tumors and Liver…
NCT00037804 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00037804 |
|---|---|
| Title | Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Chemotherapy, Liver Dysfunction, Neoplasms, Solid Tumor |
| Intervention type | Drug |
| Interventions | Irinotecan |
| First posted | May 22, 2002 |
| Last update posted | Aug 14, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: